Article Text
Therapeutics
Review: infliximab increases response and remission rates in fistulising or treatment-resistant Crohn’s disease
Statistics from Altmetric.com
Footnotes
-
Source of funding: not stated.
-
For correspondence: Dr J K Marshall, McMaster University, Hamilton, ON, Canada. Email marshallj{at}mcmaster.ca.